Uli K. Chettipally

Dr. Uli K. Chettipally is an award-winning researcher, public speaker, and pioneering physician specializing in healthcare technology and innovation consulting. He is the Founder and President of InnovatorMD: the world’s largest physician innovation company devoted to globally advancing solutions that revolutionize patient care.

As a result of his work with CREST Network in developing a clinical decision support platform, Dr. Uli Chettipally earned the Pioneer award for innovation from Kaiser Permanente. He also received the Morris F. Collen award, for his research with his team from The Permanente Medical Group. In addition to that, Dr. Chettipally has participated in the White House Champions of Change in Precision Medicine: providing input regarding the digital transformation of healthcare in the United States.

Most recently in 2021 Dr. Chettipally founded Sirica Therapeutics which is developing a therapeutic device for autism using advance robotics, immersive virtual reality and machine learning. Dr Chettipally’s SF Bay Area experience includes Founder, President of Innovator MD; Director – Health Accelerator, Founder Institute; Clinical Advisor, Anthem Inc.; Assistant Clinical Professor of Medicine, UCSF; Cofounder and CTO of CREST Network, Chairman, Research Committee, Kaiser Permanente; Emergency Physician and Chair of Emergency Department, The Permanente Group

In addition, Dr Chettipally currently serves on the board of the San Mateo County Medical Association; Advisory Board member, American Board of Artificial Intelligence in Medicine; and Chairman of the Board, Clearwater Ranch.

Dr Chettipally earned an MD from Osmania University and an Epidemiology MPH from UCLA.